Entheon Biomedical Corp. (CSE:ENBI.X)
Canada · Delayed Price · Currency is CAD 0.0600
0.00 (0.00%)
At close: Sep 2, 2026
Entheon Biomedical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
831.54K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2025 | - | - | - |
| Nov 30, 2024 | - | - | - |
| Nov 30, 2023 | 250.32K | 60.65K | 31.97% |
| Nov 30, 2022 | 189.68K | - | - |
| Nov 30, 2021 | - | - | - |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Entheon Biomedical News
- 2 months ago - CORRECTION FROM SOURCE: Entheon Biomedical Corp. Issues Correction to News Release Dated June 9, 2026 - Newsfile Corp
- 2 months ago - Entheon Announces Change of Directors - Newsfile Corp
- 3 months ago - Entheon Announces Termination of Business Combination Agreement with Nutravisor - Newsfile Corp
- 7 months ago - Entheon Announces Execution of Business Combination Agreement with Nutravisor - Newsfile Corp
- 8 months ago - Entheon Announces Letter of Intent with Nutravisor Inc. - Newsfile Corp
- 1 year ago - Entheon Issues Incentive Stock Options - Newsfile Corp
- 1 year ago - Entheon Announces Termination of Mentis AI Agreement - Newsfile Corp
- 1 year ago - Entheon Announces Agreement to Acquire Mentis AI - Newsfile Corp